Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia

Fida Khater, Mathieu Lajoie, Sylvie Langlois, Jasmine Healy, Sonia Cellot, Chantal Richer, Patrick Beaulieu, Pascal St-Onge, Virginie Saillour, Mark Minden, Monia Marzouki, Maja Krajinovic, Henrique Bittencourt, Daniel Sinnett

Blood (2017) 129 (12): 1729–1732.

https://doi.org/10.1182/blood-2016-10-744219

Published: 2017

Includes: Supplemental data

Journal Articles

PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia

Stephanie Tung, Yonghong Shi, Karry Wong, Fang Zhu, Reg Gorczynski, Robert C. Laister, Mark Minden, Anne-Kareen Blechert, Yvonne Genzel, Udo Reichl, David E. Spaner

Blood (2013) 122 (6): 969–980.

https://doi.org/10.1182/blood-2013-03-489468

Published: 2013

Includes: Supplemental data

Journal Articles

Treatment of Adult T-ALL with a Pediatric Asparaginase-Intensive Protocol Results in Survival Benefit When Compared to Other Adult Based Protocols

Murtadha K. Al-Khabori, BSc, MD, FRCPC, Mark Minden, Vikas Gupta, Aaron D. Schimmer, Andre C. Schuh, Karen WL Yee, Wei Xu, Joseph M. Brandwein

Blood (2008) 112 (11): 3956.

https://doi.org/10.1182/blood.V112.11.3956.3956

Published: 2008

Journal Articles

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

Susan Kao, MD, Wei Xu, PhD, Vikas Gupta, MD, MRCP, MRCPath, Mark Minden, Andre Schuh, MD, Aaron D. Schimmer, Karen WL Yee, Joseph Brandwein, MD, FRCPC

Blood (2008) 112 (11): 3962.

https://doi.org/10.1182/blood.V112.11.3962.3962

Published: 2008

Journal Articles

An Upstream Insulator Element Regulates DLK1 Imprinting in AML

Haytham Khoury, MD, Fernando Suarez-Saiz, Samantha Wu, Serban San-Marina, Mark Minden

Blood (2008) 112 (11): 202.

https://doi.org/10.1182/blood.V112.11.202.202

Published: 2008

Journal Articles

Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML)

Mark Minden, David Rosen, Santosh Putta, Aileen Cohen, Helen Francis-Lang, Todd Covey, John Woronicz, David Soper, Brian Long, James Cordeiro, Lootsie Panganiban-Lustan, Steve Banville, Urte Gayko, Alessandra Cesano, Wendy Fantl

Blood (2008) 112 (11): 2549.

https://doi.org/10.1182/blood.V112.11.2549.2549

Published: 2008

Journal Articles

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Guillermo Garcia-Manero, Sarit Assouline, Jorge Cortes, Zeev Estrov, Hagop Kantarjian, Hui Yang, Willie M. Newsome, Wilson H. Miller, Jr, Caroline Rousseau, Ann Kalita, Claire Bonfils, Marja Dubay, Tracy-Ann Patterson, Zuomei Li, Jeffrey M. Besterman, Gregory Reid, Eric Laille, Robert E. Martell, Mark Minden

Blood (2008) 112 (4): 981–989.

https://doi.org/10.1182/blood-2007-10-115873

Published: 2008

Includes: Supplemental data

Journal Articles

Impact of Myeloablative Versus Reduced Intensity Conditioning Regimens on Early Lymphocyte Recovery and Its Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients with Hematologic Malignancies.

Dong Hwan (Dennis) Kim, MD, PhD, Gizelle Popradi, MD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD, PhD, Jeffrey H. Lipton, MD, PhD, Hans A. Messner, MD, PhD

Blood (2007) 110 (11): 5039.

https://doi.org/10.1182/blood.V110.11.5039.5039

Published: 2007

Journal Articles

Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Dong Hwan (Dennis) Kim, MD, PhD, Gizelle Popradi, MD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD, PhD, Hans A. Messner, MD, PhD, Jeffrey H. Lipton, MD, PhD

Blood (2007) 110 (11): 1062.

https://doi.org/10.1182/blood.V110.11.1062.1062

Published: 2007

Journal Articles

Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS.

Gizelle Popradi, MD, Dong Hwan (Dennis) Kim, MD/PhD, John Kuruvilla, MD, Vikas Gupta, MD, Mark Minden, MD/PhD, Jeffrey H. Lipton, MD/PhD, Hans A. Messner, MD/PhD

Blood (2007) 110 (11): 1102.

https://doi.org/10.1182/blood.V110.11.1102.1102

Published: 2007

Journal Articles

Presence of Comorbidities Do Not Predict Early Mortality or Survival in Older Patients (≥60 Years) with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Therapy.

Vikas Gupta, Christine Keng, Wei Xu, Joseph Brandwein, Aaron Schimmer, Andre Schuh, Karen Yee, Mark Minden, Shabbir Alibhai

Blood (2006) 108 (11): 4489.

https://doi.org/10.1182/blood.V108.11.4489.4489

Published: 2006

Journal Articles

A Phase I Study of the Histone Deacetylase Inhibitor MGCD0103 (MG-0103) Given as a Three-Times Weekly Oral Dose in Patients with Leukemia or Myelodysplastic Syndromes (MDS).

Guillermo Garcia-Manero, MD, Mark Minden, MD, Zeev Estrov, MD, Srdan Verstovsek, MD, Jackie Fiorentino, RN, Hagop Kantarjian, MD, Gregory Reid, Robert E. Martell, MD, PhD

Blood (2005) 106 (11): 4639.

https://doi.org/10.1182/blood.V106.11.4639.4639

Published: 2005

Journal Articles

Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.

Joerg M. Aswald, MD MSc, Xing-Hua Wang, MD, Sandra Aswald, MD MSc, Loralyn A. Benoit, BSc, Mark Minden, MD PhD, Hans A. Messner, MD PhD, Armand Keating, MD

Blood (2004) 104 (11): 2538.

https://doi.org/10.1182/blood.V104.11.2538.2538

Published: 2004

NARROW

KMT2E-ASNS: a novel relapse-specific fusion gene in early T-cell precursor acute lymphoblastic leukemia

PPARα and fatty acid oxidation mediate glucocorticoid resistance in chronic lymphocytic leukemia

Treatment of Adult T-ALL with a Pediatric Asparaginase-Intensive Protocol Results in Survival Benefit When Compared to Other Adult Based Protocols

Outcome of Patients Age 60 and Over with Acute Lymphoblastic Leukemia (ALL) Treated with a Modified Pediatric Protocol

An Upstream Insulator Element Regulates DLK1 Imprinting in AML

Distinct Proteomic Signaling Networks Stratify Responses to Ara-C Based Induction Therapy in Patients with Acute Myeloid Leukemia (AML)

Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia

Impact of Myeloablative Versus Reduced Intensity Conditioning Regimens on Early Lymphocyte Recovery and Its Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients with Hematologic Malignancies.

Late Onset Eosinophilia (beyond Day 100), Rather Than Early Onset Eosinophilia, Has a Significant Prognostic Impact on Transplant Outcomes after Allogeneic Peripheral Blood Stem Cell Transplantation (PBSCT).

Early Recovery of Absolute Lymphocyte Count (ALC) Is a Predictor of Long-Term Outcome Following Related Allogeneic Peripheral Blood Stem Cell Transplantation in Adults with AML/MDS.

Presence of Comorbidities Do Not Predict Early Mortality or Survival in Older Patients (≥60 Years) with Acute Myeloid Leukemia (AML) Undergoing Intensive Induction Therapy.

A Phase I Study of the Histone Deacetylase Inhibitor MGCD0103 (MG-0103) Given as a Three-Times Weekly Oral Dose in Patients with Leukemia or Myelodysplastic Syndromes (MDS).

Autologous Gamma-Delta T (GD-T) Cells in Acute Myeloid Leukemia (AML): Potential Immune Effector Cells for Minimal Disease?.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only